Free Trial
→ The cat is out the bag (From Porter & Company) (Ad)tc pixel Free OABIW Stock Alerts

OmniAb (OABIW) Competitors

$0.12 +0.03 (+27.78%)
Closing price 05/15/2026 03:32 PM Eastern
Extended Trading
$0.12 0.00 (0.00%)
As of 05/15/2026 04:27 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.
Compare

OABIW vs. SXTPW, DRTSW, APLMW, BIVIW, and CDIOW

Should you buy OmniAb stock or one of its competitors? MarketBeat compares OmniAb with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with OmniAb include 60 Degrees Pharmaceuticals (SXTPW), Alpha Tau Medical (DRTSW), Apollomics (APLMW), BioVie (BIVIW), and Cardio Diagnostics (CDIOW). These companies are all part of the "biotechnology" industry.

How does OmniAb compare to 60 Degrees Pharmaceuticals?

60 Degrees Pharmaceuticals (NASDAQ:SXTPW) and OmniAb (NASDAQ:OABIW) are both medical companies, but which is the better business? We will contrast the two businesses based on the strength of their media sentiment, dividends, analyst recommendations, risk, valuation, profitability, institutional ownership and earnings.

In the previous week, 60 Degrees Pharmaceuticals had 1 more articles in the media than OmniAb. MarketBeat recorded 2 mentions for 60 Degrees Pharmaceuticals and 1 mentions for OmniAb. OmniAb's average media sentiment score of 1.89 beat 60 Degrees Pharmaceuticals' score of 0.44 indicating that OmniAb is being referred to more favorably in the news media.

Company Overall Sentiment
60 Degrees Pharmaceuticals Neutral
OmniAb Very Positive

Company Net Margins Return on Equity Return on Assets
60 Degrees PharmaceuticalsN/A N/A N/A
OmniAb N/A N/A N/A

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
60 Degrees Pharmaceuticals$1.01MN/AN/AN/AN/A
OmniAb$28.94MN/AN/AN/AN/A

Summary

OmniAb beats 60 Degrees Pharmaceuticals on 2 of the 3 factors compared between the two stocks.

How does OmniAb compare to Alpha Tau Medical?

OmniAb (NASDAQ:OABIW) and Alpha Tau Medical (NASDAQ:DRTSW) are both medical companies, but which is the superior business? We will compare the two companies based on the strength of their media sentiment, valuation, dividends, analyst recommendations, risk, profitability, institutional ownership and earnings.

In the previous week, Alpha Tau Medical had 2 more articles in the media than OmniAb. MarketBeat recorded 3 mentions for Alpha Tau Medical and 1 mentions for OmniAb. OmniAb's average media sentiment score of 1.89 beat Alpha Tau Medical's score of 0.19 indicating that OmniAb is being referred to more favorably in the media.

Company Overall Sentiment
OmniAb Very Positive
Alpha Tau Medical Neutral

Company Net Margins Return on Equity Return on Assets
OmniAbN/A N/A N/A
Alpha Tau Medical N/A N/A N/A

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
OmniAb$28.94MN/AN/AN/AN/A
Alpha Tau MedicalN/AN/AN/AN/AN/A

Summary

OmniAb beats Alpha Tau Medical on 2 of the 3 factors compared between the two stocks.

How does OmniAb compare to Apollomics?

OmniAb (NASDAQ:OABIW) and Apollomics (NASDAQ:APLMW) are both medical companies, but which is the superior business? We will compare the two companies based on the strength of their media sentiment, valuation, dividends, analyst recommendations, risk, profitability, institutional ownership and earnings.

Company Net Margins Return on Equity Return on Assets
OmniAbN/A N/A N/A
Apollomics N/A N/A N/A

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
OmniAb$28.94MN/AN/AN/AN/A
Apollomics$8.50MN/AN/AN/AN/A

In the previous week, OmniAb and OmniAb both had 1 articles in the media. OmniAb's average media sentiment score of 1.89 equaled Apollomics'average media sentiment score.

Company Overall Sentiment
OmniAb Very Positive
Apollomics Very Positive

Summary

OmniAb beats Apollomics on 1 of the 1 factors compared between the two stocks.

How does OmniAb compare to BioVie?

OmniAb (NASDAQ:OABIW) and BioVie (NASDAQ:BIVIW) are both medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their risk, dividends, institutional ownership, valuation, analyst recommendations, media sentiment, profitability and earnings.

In the previous week, OmniAb and OmniAb both had 1 articles in the media. OmniAb's average media sentiment score of 1.89 beat BioVie's score of 1.87 indicating that OmniAb is being referred to more favorably in the media.

Company Overall Sentiment
OmniAb Very Positive
BioVie Very Positive

Company Net Margins Return on Equity Return on Assets
OmniAbN/A N/A N/A
BioVie N/A N/A N/A

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
OmniAb$28.94MN/AN/AN/AN/A
BioVieN/AN/AN/AN/AN/A

Summary

OmniAb beats BioVie on 2 of the 2 factors compared between the two stocks.

How does OmniAb compare to Cardio Diagnostics?

OmniAb (NASDAQ:OABIW) and Cardio Diagnostics (NASDAQ:CDIOW) are both medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their risk, dividends, institutional ownership, valuation, analyst recommendations, media sentiment, profitability and earnings.

In the previous week, Cardio Diagnostics had 1 more articles in the media than OmniAb. MarketBeat recorded 2 mentions for Cardio Diagnostics and 1 mentions for OmniAb. OmniAb's average media sentiment score of 1.89 beat Cardio Diagnostics' score of 0.43 indicating that OmniAb is being referred to more favorably in the media.

Company Overall Sentiment
OmniAb Very Positive
Cardio Diagnostics Neutral

Company Net Margins Return on Equity Return on Assets
OmniAbN/A N/A N/A
Cardio Diagnostics N/A N/A N/A

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
OmniAb$28.94MN/AN/AN/AN/A
Cardio Diagnostics$14.83KN/AN/AN/AN/A

Summary

OmniAb beats Cardio Diagnostics on 2 of the 3 factors compared between the two stocks.

Get OmniAb News Delivered to You Automatically

Sign up to receive the latest news and ratings for OABIW and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

OABIW vs. The Competition

Export
MetricOmniAbBiotechnology IndustryMedical SectorNASDAQ Exchange
Market CapN/A$466.99M$6.42B$12.48B
Dividend YieldN/A3.86%2.80%5.25%
P/E RatioN/A3.8720.3825.24
Price / SalesN/A7,766.11566.1582.24
Price / CashN/A13.1343.0456.04
Price / BookN/A84.219.876.90
Net IncomeN/A-$96.07M$3.57B$334.66M
7 Day PerformanceN/A0.98%0.31%0.13%
1 Month PerformanceN/A0.43%-1.27%1.11%
1 Year Performance-61.67%69.18%33.54%30.62%

OmniAb Competitors List

Export
CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
OABIW
OmniAb
N/A$0.12
+27.8%		N/A-61.7%$0.00$28.94MN/A106
SXTPW
60 Degrees Pharmaceuticals
N/A$0.05
-0.4%		N/A-32.7%$0.00$1.01MN/A2
DRTSW
Alpha Tau Medical
N/A$0.95
-4.1%		N/A+847.1%$0.00N/AN/A80
APLMW
Apollomics
N/A$0.02
flat		N/A+27.0%$0.00$8.50MN/A59
BIVIW
BioVie
N/A$0.30
-5.9%		N/AN/A$0.00N/AN/AN/A

Related Companies and Tools

Related Companies
Top 10 Stock Comparisons

This page (NASDAQ:OABIW) was last updated on 5/16/2026 by MarketBeat.com Staff.
From Our Partners
Trump's gold order: the announcement they won't put on the front page
On August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no deb...
Reagan Gold Group | Sponsoredtc pixel
Hey, it's Jon Najarian. The SpaceX IPO is right around the corner. But I discovered Elon may have something BIGGER planned. Check this out before June 9th...
After being invited to the SpaceX launch headquarters in Cape Canaveral from one of Elon's top lobbyists… Hall...
Banyan Hill Publishing | Sponsoredtc pixel
From the man who predicted 2008 crash…
Porter Stansberry, founder of one of the largest financial research firms in the world, says he's breaking the...
Porter & Company | Sponsoredtc pixel
SpaceX just filed. The clock is ticking.
Reuters reports Elon Musk filed secretly. Barron's says it's being finalized behind closed doors. CNBC just re...
The Oxford Club | Sponsoredtc pixel
ALERT: Drop these 5 stocks before the market opens tomorrow!
The Wall Street Journal is already raising the alarm about a potential market crash, and Weiss Ratings researc...
Weiss Ratings | Sponsoredtc pixel
RIP Grok?
Elon Musk just dissolved xAI and leased his Colossus data center to a competitor - and analyst Marc Chaikin sa...
Chaikin Analytics | Sponsoredtc pixel
Oil is settling in yuan now - here's what that means for gold
Saudi Arabia has terminated its 1974 petrodollar agreement with the United States - the deal that forced every...
Golden Portfolio | Sponsoredtc pixel
Your book is inside
The "Sucker's Bet" Most New Options Traders Fall For Most people who try options lose money the same way. ...
Profits Run | Sponsoredtc pixel